Arcturus Therapeutics Holdings Inc.
ARCT
$6.72
$0.172.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.08M | -13.45M | -9.18M | -14.08M | -30.01M |
| Total Depreciation and Amortization | 682.00K | 763.00K | 779.00K | 801.00K | 819.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.78M | 5.90M | 6.33M | 6.68M | 8.81M |
| Change in Net Operating Assets | 3.39M | -10.37M | -3.68M | -28.55M | 20.09M |
| Cash from Operations | -16.23M | -17.15M | -5.76M | -35.14M | -284.00K |
| Capital Expenditure | 88.00K | -181.00K | 0.00 | -137.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 88.00K | -181.00K | 0.00 | -137.00K | 0.00 |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 15.00M | -- |
| Total Debt Repaid | 0.00 | 0.00 | -15.00M | -- | -- |
| Issuance of Common Stock | 11.69M | 1.23M | 274.00K | 195.00K | 134.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.69M | 1.23M | -14.73M | 15.20M | 134.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.45M | -16.11M | -20.48M | -20.08M | -150.00K |